
Major reinvestment from AstraZeneca confirms Canada’s vital role in clinical trials
On February 27, 2023, one day before Rare Disease Day, U.K.-based biopharmaceutical company AstraZeneca and Alexio
8 total items
On February 27, 2023, one day before Rare Disease Day, U.K.-based biopharmaceutical company AstraZeneca and Alexio